Mirum Pharmaceuticals, Inc. (MIRM) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $1.7M. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | — | +8,390 | +23% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER | $2,872,321 | 90,000 | 0% | Yes | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 18, 2026 | Howe Jolanda SVP, GLOBAL CONTROLLER | $3,749,200 | 120,000 | — | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 11, 2026 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | −$599,510 | 6,001 | −14% | Yes | |
|
|
||||||
| Aug. 11, 2026 filed Aug. 10, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER | $1,919,682 | 60,000 | 0% | Yes | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free